Halozyme Therapeutics Inc
HALO67.350USD
+2.240+3.44%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
7.92BMarket Cap
13.79P/E TTM
Halozyme Therapeutics Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
1.02B
22.44%
EPS(YoY)
3.50
64.05%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Halozyme Therapeutics Inc?
According to Halozyme Therapeutics Inc's FY2024 earnings report, its total revenue reached 1.02B, with a year-on-year change of 22.44%.
What is the Earnings Per Share (EPS) of Halozyme Therapeutics Inc?
According to Halozyme Therapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was 3.502, with a year-on-year change of 64.05%.
What is the net income of Halozyme Therapeutics Inc?
According to Halozyme Therapeutics Inc's FY2024 earnings report, its net income was 444.09M, with a year-on-year change of 57.71%.
What is the net margin of Halozyme Therapeutics Inc?
According to Halozyme Therapeutics Inc's FY2024 earnings report, its net profit margin was 43.74%, with a year-on-year change of 28.80%.
What is the gross margin of Halozyme Therapeutics Inc?
According to Halozyme Therapeutics Inc's FY2024 earnings report, its gross margin was 77.30%, with a year-on-year change of 13.33%.
What is the debt-to-asset ratio of Halozyme Therapeutics Inc?
According to Halozyme Therapeutics Inc's FY2024 earnings report, its debt-to-asset ratio was 72.97%, with a year-on-year change of -15.64%.
What is the Return on Equity (ROE) of Halozyme Therapeutics Inc?
According to Halozyme Therapeutics Inc's FY2024 earnings report, its Return on Equity (ROE) was 198.42%, with a year-on-year change of -10.65%.
What is the Return on Assets (ROA) of Halozyme Therapeutics Inc?
According to Halozyme Therapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was 23.39%, with a year-on-year change of 48.49%.
What is the operating profit of Halozyme Therapeutics Inc?
According to Halozyme Therapeutics Inc's FY2024 earnings report, its operating profit was 551.48M, with a year-on-year change of 62.16%.
What are the current assets of Halozyme Therapeutics Inc?
According to Halozyme Therapeutics Inc's FY2024 earnings report, its current assets were 1.09B, with a year-on-year change of 45.41%.
What are the total assets of Halozyme Therapeutics Inc?
According to Halozyme Therapeutics Inc's FY2024 earnings report, its total assets of Halozyme Therapeutics Inc were 2.06B, with a year-on-year change of 19.05%.
What are the total liabilities of Halozyme Therapeutics Inc?
According to Halozyme Therapeutics Inc's FY2024 earnings report, its total liabilities of Halozyme Therapeutics Inc were 1.70B, with a year-on-year change of 3.04%.
What is the total equity of Halozyme Therapeutics Inc?
According to Halozyme Therapeutics Inc's FY2024 earnings report, its total equity of Halozyme Therapeutics Inc was 363.82M, with a year-on-year change of 334.11%.
What is the net operating income of Halozyme Therapeutics Inc?
According to Halozyme Therapeutics Inc's FY2024 earnings report, its net operating income of Halozyme Therapeutics Inc was 444.09M, with a year-on-year change of 57.71%.
What is the net investment of Halozyme Therapeutics Inc?
According to Halozyme Therapeutics Inc's FY2024 earnings report, its net investment of Halozyme Therapeutics Inc was -262.72M, with a year-on-year change of -171.10%.
What is the net financing of Halozyme Therapeutics Inc?
According to Halozyme Therapeutics Inc's FY2024 earnings report, its net financing of Halozyme Therapeutics Inc was -218.86M, with a year-on-year change of 46.36%.
